Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 3, 2013, Pages 2619-2628

  Karki, Rajendra ^a,b   Ho, Oak Min ^b   Kim, Dong Wook ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Mokpo National University   (South Korea)

Author keywords

Cell cycle regulator; Magnolol; Neointima; Restenosis; Vascular smooth muscle cell

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAGNOLOL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TICLOPIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY INJURY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; G0 CELL CYCLE ARREST; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NEOINTIMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIPHENYL COMPOUNDS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; LIGNANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84872811571     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.12.015     Document Type: Article

References (54)

1. D. Greenberg, A. Bakhai, and D.J. Cohen Can we afford to eliminate restenosis? Can we afford not to? J. Am. Coll. Cardiol. 43 2004 513 518
2. P.P. Dobesh, Z.A. Stacy, A.J. Ansara, and J.M. Enders Drug-eluting stents: a mechanical and pharmacological approach to coronary artery disease Pharmacotherapy 24 2004 1554 1577
3. A.A. Bavry, D.J. Kumbhani, T.J. Helton, and D.L. Bhatt Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data) Am. J. Cardiol. 95 2005 1469 1472
4. D.W. Nilsen, T. Melberg, A.I. Larsen, S. Barvik, and V. Bonarjee Late complications following the deployment of drug-eluting stents Int. J. Cardiol. 109 2006 398 401
5. M.A. Reidy Factors controlling smooth-muscle cell proliferation Arch. Pathol. Lab. Med. 116 1992 1276 1280
6. S.M. Schwartz, M.W. Majesky, and C.E. Murry The intima: development and monoclonal responses to injury Atherosclerosis 118 1995 125 140
7. J.J. Fuster, P. Fernandez, H. Gonzalez-Navarro, C. Silvestre, Y.N.A. Nabah, and V. Andres Control of cell proliferation in atherosclerosis: insights from animal models and human studies Cardiovasc. Res. 86 2010 254 264
8. S. Tanizawa, M. Ueda, C.M. van der Loos, A.C. van der Wal, and A.E. Becker Expression of platelet-derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study Heart 75 1996 549 556
9. F. Sigala, P. Sawari, M. Liontos, P. Sigalas, L.S. Pateras, A. Papalampros, E.K. Basdra, E. Kolettas, A. Kotsinas, A.G. Papavassiliou, and V.G. Gorgoulis Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging NF-κB pathway J. Cell. Mol. Med. 14 2010 2273 2280
10. P.S. Monraats, N.M.M. Pires, A. Schepers, W.R.P. Agema, L.S.M. Boesten, M.R. de Vries, A.H. Zwinderman, M.P. de Maat, P.A. Doevendans, R.J. de Winter, R.A. Tio, J. Waltenberger, L.M. Hart, R.R. Frants, P.H. Quax, B.J. van Vlijmen, L.M. Havekes, A. van der Laarse, E.E. van der Wall, and J.W. Jukema Tumor necrosis factor-α plays an important role in restenosis development FASEB J. 19 2005 1998 2004
11. Z. Mallat, and A. Tedgui The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives Curr. Opin. Lipidol. 13 2002 523 529
12. W. Koch, K. Tiroch, N. von Beckerath, A. Schomig, and A. Kastrati Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting Cytokine 24 2003 161 171
13. J.E. Rectenwald, L.L. Moldawer, T.S. Huber, J.M. Seeger, and C.K. Ozaki Direct evidence for cytokine involvement in neointimal hyperplasia Circulation 102 2000 1697 1702
14. E.M. Rzucidlo Signaling pathways regulating vascular smooth muscle cell differentiation Vascular 17 2009 15 20
15. C.H. Chung, K.T. Lin, C.H. Chang, H.C. Peng, and T.F. Huang The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-κB translocation and PDGF production Br. J. Pharmacol. 156 2009 846 856
16. A.R. Yoo, S.H. Koh, G.W. Cho, and S.H. Kim Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway J. Atheroscler. Thromb. 17 2010 1009 1018
17. T. Masaki, R. Foti, P.A. Hill, Y. Ikezumi, R.C. Atkins, and D.J. Nikolic-Paterson Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney Kidney Int. 63 2003 1256 1264
18. Y. Izumi, S. Kim, M. Namba, H. Yasumoto, H. Miyazaki, M. Hoshiga, Y. Kaneda, R. Morishita, Y. Zhan, and H. Iwao Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery Circ. Res. 88 2001 1120 1126
19. K. Brand, S. Page, G. Rogler, A. Bartsch, R. Brandl, R. Kneuchel, M. Page, C. Kaltschmidt, P.A. Baeuerle, and D. Neumeier Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion J. Clin. Invest. 97 1996 1715 1722
20. + 2 channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta Life Sci. 47 1990 1153 1161
21. S.C. Chen, Y.L. Chang, D.L. Wang, and J.J. Cheng Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells Br. J. Pharmacol. 148 2006 226 232
22. Y.H. Chen, S.J. Lin, J.W. Chen, H.H. Ku, and Y.L. Chen Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits Br. J. Pharmacol. 135 2002 37 47
23. K.H. Bang, Y.K. Kim, B.S. Min, M.K. Na, Y.H. Rhee, J.P. Lee, and K.H. Bae Antifungal activity of magnolol and honokiol Arch. Pharm. Res. 23 2000 46 49
24. D.W. Kim, H.J. Chung, K. Nose, I. Maruyama, and T. Tani Preventive effects of a traditional Chinese formulation, Chaihu-jia-Longgu-Muli-tang, on intimal thickening of carotid artery injured by balloon endothelial denudation in rats J. Pharm. Pharmacol. 54 2002 571 575
25. T. Goncu, O. Tiryakioglu, A. Ozcan, H. Ari, M. Sezen, H. Vural, A. Bayer, S. Yalcinkaya, S. Yavuz, and A. Ozyazicioglu Inhibitory effects of ticlopidine and clopidogrel on the intimal hyperplastic response after arterial injury Anadolu Kardiyol. Derg. 10 2010 11 16
26. Y.M. Yu, H.C. Lin, and W.C. Chang Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9 Br. J. Nutr. 100 2008 731 738
27. S. Arora, A. Bhardwaj, S.K. Srivastava, S. Singh, S. McClellan, B. Wang, and A.P. Singh Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells PLoS One 6 2011 e21573
28. K.W. Liang, S.C. Yin, C.T. Ting, S.J. Lin, C.M. Hsueh, C.Y. Chen, and S.L. Hsu Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells Eur. J. Pharmacol. 590 2008 343 354
29. J.J. Yoon, Y.J. Lee, J.S. Kim, D.G. Kang, and H.S. Lee Betulinic acid inhibits high glucose-induced vascular smooth muscle cells proliferation and migration J. Cell. Biochem. 111 2011 1501 1511
30. F.J. Neumann, M. Gawaz, T. Dickfeld, A. Wehinger, H. Walter, R. Blasini, and A. Schomig Antiplatelet effect of ticlopidine after coronary stenting J. Am. Coll. Cardiol. 29 1997 1515 1519
31. R. Karki, E.R. Jeon, and D.W. Kim Magnoliae Cortex inhibits intimal thickening of carotid artery through modulation of proliferation and migration of vascular smooth muscle cells Food Chem. Toxicol. 50 2012 634 640
32. E.J. Topol, F. Leya, C.A. Pinkerton, P.L. Whitlow, B. Hofling, C.A. Simonton, R.R. Masden, P.W. Serruys, M.B. Leon, D.O. Williams, S.B. King, D.B. Mark, J.M. Isner, D.R. Holmes, S.G. Ellis, K.L. Lee, G.P. Keeler, L.G. Berdan, T. Hinohara, and R.M. Califf Comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease N. Engl. J. Med. 329 1993 222 227
33. A.V. Finn, G. Nakazawa, M. Joner, F.D. Kolodgie, E.K. Mont, H.K. Gold, and R. Virmani Vascular responses to drug eluting stents: importance of delayed healing Arterioscler. Thromb. Vasc. Biol. 27 2007 1500 1510
34. J.S. Douglas Role of adjunct pharmacologic therapy in the era of drug-eluting stents Atheroscler. Suppl. 6 2005 47 52
35. A. Lafont, and D. Faxon Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials Cardiovasc. Res. 39 1998 50 59
36. T. Inoue, and K. Node Molecular basis of restenosis and novel issues of drug eluting stents Circ. J. 73 2009 615 621
37. A.W. Clowes, M.A. Reidy, and M.M. Clowes Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab. Invest. 49 1983 327 333
38. J. Fingerle, R. Johnson, A.W. Clowes, M.W. Majesky, and M.A. Reidy Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery Proc. Natl. Acad. Sci. U. S. A. 86 1989 8412 8416
39. J.K. Chung, T. Lee, I.M. Jung, Y.K. Kim, S.K. Min, J.W. Suh, and S.J. Kim Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery J. Korean Med. Sci. 19 2004 327 332
40. S.J. Park, H.S. Kim, H.M. Yang, K.W. Park, S.W. Youn, S.I. Jeon, D.H. Kim, B.K. Koo, I.H. Chae, D.J. Choi, B.H. Oh, M.M. Lee, and Y.B. Park Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery Arterioscler. Thromb. Vasc. Biol. 24 2004 885 891
41. V.J. Dzau, R.C. Braun-Dullaeus, and D.G. Sedding Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat. Med. 8 2002 1249 1256
42. S. Kim, and H. Iwao Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling J. Pharmacol. Sci. 91 2003 177 181
43. A. Muto, T.N. Fitzgerald, J.M. Pimiento, S.P. Maloney, D. Teso, J.J. Paszkowiak, T.S. Westvik, F.A. Kudo, T. Nishibe, and A. Dardik Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons J. Vasc. Surg. 45 2007 15 24
44. R.K. Dubey, E.K. Jackson, D.G. Gillespie, L.C. Zacharia, B. Imthurn, and P.J. Keller Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity Arterioscler. Thromb. Vasc. Biol. 20 2000 964 972
45. A.M. Abukhdeir, and B.H. Park P21 and P27: roles in carcinogenesis and drug resistance Expert Rev. Mol. Med. 10 2008 e19
46. H.M. Kim, S.J. Bae, D.W. Kim, B.Y. Kim, S.B. Lee, U.S. Lee, C.H. Kim, and S.K. Moon Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-α induced vascular smooth muscle cells Int. Immunopharmacol. 7 2007 1083 1091
47. R. Morishita, G.H. Gibbons, K.E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara, and V.J. Dzau Intimal hyperplasia after vascular injury is inhibited by antisense CDK2 kinase oligonucleotides J. Clin. Invest. 93 1994 1458 1464
48. M.W. Chang, E. Barr, J. Seltzer, Y.Q. Jiang, G.J. Nabel, E.G. Nabel, M.S. Parmacek, and J.M. Leiden Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science 267 1995 518 522
49. Kip1-dependent mechanism J. Clin. Invest. 114 2004 419 426
50. N.D. Perkins Integrating cell-signalling pathways with NF-κB and IKK function Nat. Rev. Mol. Cell Biol. 8 2007 49 62
51. H.M. Zhang, L. Li, N. Papadopoulou, G. Hodgson, E. Evans, M. Galbraith, M. Dear, S. Vougier, J. Saxton, and P.E. Shaw Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1 Nucleic Acids Res. 36 2008 2594 2607
52. Y. Lim, M. Tudev, E.S. Park, W.S. Kim, I.H. Lim, M.Y. Lee, H. Lee, J.K. Jung, J.T. Hong, H.S. Yoo, M.K. Lee, M.Y. Pyo, and Y.P. Yun Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells Arch. Pharm. Res. 34 2011 1191 1199
53. J.H. Ho, and C.Y. Hong Cardiovascular protection of magnolol: cell-type specificity and dose-related effects J. Biomed. Sci. 19 2012 70
54. H.C. Ou, F.P. Chou, W.H. Sheu, S.L. Hsu, and W.J. Lee Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells Arch. Toxicol. 81 2007 421 432